EPO analogues and iron replacement are the current treatments for anemia, but the Food and Drug Administration (FDA) has issued a warning for the usage of EPO analogues because their usage results in a greater risk of serious side effects (Besarab et al., 2015). This evidence concerns the gene EPO and anemia (phenotype).